FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2024/11/077146 [Registered on: 20/11/2024] Trial Registered Prospectively
Last Modified On: 09/11/2024
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Single Arm Study 
Public Title of Study   Impact of Non-Invasive Ventilation on Chest Ultrasound Findings in Patients with Acute Respiratory Failure and its link to Ventilation Success or Failure 
Scientific Title of Study   Study of Respiratory Mechanics using Ultrasound in Acute Respiratory Failure before and after Non-Invasive Ventilation 
Trial Acronym  NILL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Ashish Gupta 
Designation  DrNB student 
Affiliation  Artemis Hospitals Gurugram 
Address  Departement of Critical Care unit II, Artemis Hospitals, Sector 51, Gurugram, Haryana, India

Gurgaon
HARYANA
122001
India 
Phone    
Fax    
Email  ashishg19995@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Kuldeep Singh 
Designation  Associate chief 
Affiliation  Artemis Hospitals Gurugram 
Address  Departement of Critical Care unit II, Artemis Hospitals, Sector 51, Gurugram, Haryana, India

Gurgaon
HARYANA
122001
India 
Phone  01244511111  
Fax    
Email  kuldeep@artemishospitals.com  
 
Details of Contact Person
Public Query
 
Name  Dr Kuldeep Singh 
Designation  Associate chief 
Affiliation  Artemis Hospitals Gurugram 
Address  Departement of Critical Care unit II, Artemis Hospitals, Sector 51, Gurugram, Haryana, India


HARYANA
122001
India 
Phone  01244511111  
Fax    
Email  kuldeep@artemishospitals.com  
 
Source of Monetary or Material Support  
Departemnt of Critical Care, Artemis Hospitals, Sector 51, Gurugram 122001 Haryana, India 
 
Primary Sponsor  
Name  Dr Ashish Gupta 
Address  Departement of Critical Care, Artemis Hospitals, Sector 51, Gurugram 122001 Haryana, India 
Type of Sponsor  Other [self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Ashish Gupta  Artemis Hospitals  Department of Critical Care-Unit II, second floor, Artemis Hospitals, Sector 51, Gurugram 122001 Haryana, India
Gurgaon
HARYANA 
8683054779

ashishg19995@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Artemis Health Sciences IEC   Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: J960||Acute respiratory failure,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  nil  nil 
Intervention  nil  nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  99.00 Year(s)
Gender  Both 
Details  Patients admitted in Intensive Care Unit (ICU) with
1. Acute respiratory failure
2. PaO2/FiO2 less than 300
3. Including Type I Respiratory Failure, Type II Respiratory Failure and patients with increased work of breathing, and
4. scheduled for NIV trial 
 
ExclusionCriteria 
Details  1. Patient refusal
2. Age less than 18 years
3. All contraindications to NIV
4. Non-compliance to NIV
5. Patients on domiciliary NIV support
6. Patients with chest wall deformity
7. Patients with recent history of chest or abdominal surgery (within 1 month)
8. Any structural change in chest and abdomen ultrasound which confound the ultrasound parameters
9. Poor echogenic window
10. Obesity (BMI more than 35kg per m2)
11. Pregnant patients
12. Patients with pre-existing Diaphragm paralysis
13. Patients with pre-existing Neuromuscular disorders
14. Patients with history of diaphragm surgery
15. Patients who refused for invasive mechanical ventilation
16. Patients requiring planed intubation for any procedure or surgery
 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
Changes in lung ultrasound score, diaphragm excursion, diaphragm thickening fraction, parasternal intercostal muscle thickening fraction, and expiratory abdominal muscle thickening fraction after institution of NIV. Association of these parameters with NIV failure.  Baseline
6,12,24,48 hours after initiation on NIV 
 
Secondary Outcome  
Outcome  TimePoints 
Association of above mentioned ultrasound parameters with ICU stay duration, hospital stay duration and ICU and in-hospital mortality.  Baseline
6,12,24,48 hours after initiation on NIV, till discahrge of the patient 
 
Target Sample Size   Total Sample Size="65"
Sample Size from India="65" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   05/12/2024 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="6"
Days="0" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

Study title: Study of Respiratory Mechanics using Ultrasound in Acute Respiratory Failure before and after Non-Invasive Ventilation

Study Aim: The aim is to study the respiratory mechanics using ultrasound in patients with Acute Respiratory Failure before and after institution of Non-Invasive Ventilation.

Study Design: Prospective, observational single centre study

Study Area: Intensive Care Unit, Artemis Hospitals, Gurgaon; a tertiary care centre

Study Duration: 18 months

Sample size: 65 patients

Inclusion criteria: Patients admitted in Intensive Care Unit (ICU) with acute respiratory failure (PaO2/FiO2 <300), including Type I Respiratory Failure, Type II Respiratory Failure and patients with increased work of breathing, and scheduled for Non-invasive ventilation (NIV) trial.

Exclusion criteria: Patient refusal, Age less than 18 years, all contraindications to NIV, Non-compliance to NIV, patients on domiciliary NIV support, patients with chest wall deformity, patients with recent history of chest or abdominal surgery (within 1 month), any structural change in chest and abdomen ultrasound which confound the ultrasound parameters, poor echogenic window, obesity (BMI> 35kg/m2), pregnant patients, patients with pre-existing Diaphragm paralysis, patients with pre-existing Neuromuscular disorders, patients with history of diaphragm surgery, patients who refused for invasive mechanical ventilation, and patients requiring planed intubation for any procedure or surgery.

Parameters to be measured: Respiratory parameters (respiratory rate, use of accessory muscles), Hemodynamic parameters (Heart rate, Blood pressure, Oxygen saturation), Arterial blood analysis parameters (partial pressure of oxygen-PaO2, partial pressure of carbon dioxide-PaCO2, fraction of inspired oxygen-FiO2, bicarbonate levels, PaO2/FiO2 ratio), Ultrasound parameters (lung ultrasound score, diaphragm excursion, diaphragm thickening fraction, parasternal intercostal muscle thickening fraction, and expiratory abdominal muscle thickening fraction), and Ventilator parameters (FiO2, PEEP, PS over PEEP,  Ppeak) at baseline, and at 6,12,24,48 hours.

Outcome measures: Changes in lung ultrasound score, diaphragm excursion, diaphragm thickening fraction, parasternal intercostal muscle thickening fraction, and expiratory abdominal muscle thickening fraction after institution of NIV. Association of these parameters with NIV failure, ICU stay duration, hospital stay duration and ICU & in-hospital mortality.

Statistical analysis: The data will be entered in Microsoft Excel and statistical analysis will be done using Statistical Package for Social Sciences (SPSS) software version version 23 (IBM Corp.). Appropriate statistical tests will be applied according to the nature of the data. P value <0.05 will be considered as statistically significant


 
Close